Effects of bisphosphonate on the release of MMP-2 from cultured human osteoblasts

Tohoku Journal of Experimental Medicine

Volumn 192, Issue 2, 2000, Pages 111-118

  Ichinose, Yasufumi ^a   Migita, Kiyoshi ^a   Nakashima, Tomoki ^a   Kawakami, Atsushi ^a   Aoyagi, Takahiko ^b   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Ureshino Medical Center   (Japan)

Author keywords

Bisphosphonates; Matrix metalloproteinases; Osteoblast; Plasmin

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ETIDRONIC ACID; GELATINASE A; PLASMIN;

ARTICLE; CHELATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME RELEASE; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NORMAL HUMAN; OSTEOBLAST; OSTEOLYSIS; PROTEIN DEGRADATION;

ANTIBODIES, MONOCLONAL; CELLS, CULTURED; DIPHOSPHONATES; EXTRACELLULAR MATRIX; HUMANS; IMMUNOBLOTTING; MATRIX METALLOPROTEINASE 2; OSTEOBLASTS; PLASMIN;

EID: 0034461235     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.192.111     Document Type: Article

References (17)

1. Baron, R. (1989) Molecular mechanisms of bone resorption by osteoclast. Anal. Rec., 224, 317-324.
2. Blair, H.C., Teitelbaum, S.L., Ghiselli, R. & Gluck, S. (1989) Osteoclastic bone resorption by a polarized vacuolar proton pump. Science, 245, 855-857.
3. Delaisse, J.M., Feckhout, Y., Neff, L., Francois-Gillet, C., Henriet, P., Su, Y., Vaes, G. & Baron, R. (1993) (Pro) collagenase (matrix metalloproteinase-1) is present in rodent osteoclasts and underlying bone-resorbing compartment. J. Cell. Science, 106, 1071-1082.
4. Everts, T., Delaisse, J.M., Korper, W., Neihof, A., Vaes, G. & Beerts, W. (1992) Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cystein-proteinases and marrix metalloproteinases. J. Cell. Physiol., 150, 221-231.
5. Farina, A.R., Tacconelli, A., Teti, A., Gulino, A. & Mackay, A.R. (1998) Tissue inhibitor of metalloproteinase-2 protection of matrix metalloproteinase-2 from degradation by plasmin is reversed by divalent cation chelator EDTA and the bisphosphonate alendronate. Cancer. Res., 58, 2957-2960.
6. Fleisch, H., Russell, R.G.C. & Francis, M.D. (1969) Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo. Science, 165, 1262-1264.
7. Gerhon, R.P., Shen, L.W.F., Young, M.F. & Termine, J.D. (1988) The biochemistry of bone. In: Osteoporosis, edited by B.L. Riggs, Raven Press, New York, pp. 95-109.
8. Kusano, K., Miyaura, C., Inada, M., Tamura, T., Ito, A., Nagase, H., Kamoi, K. & Suda, T. (1998) Regulation of matrix metalloproteinases (MMP-2, -3, -9 and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology, 139, 1338-1345.
9. Lowry, O.H., Roberts, N.R., Wu, M.L., Hixon, W.S. & Crawford, E.J. (1954) The quantitative histochemistry of brain. J. Biol. Chem., 233, 19-37.
10. Matrisian, L.M. (1990) Metalloproteinase and their inhibitors in tissue remodeling. Trend. Genetics., 6, 121-125.
11. Mazzieeri, R., Masiero, L., Zanetta, L., Monea, S., Onisto, M., Garbisa, S. & Mignatti, P. (1997) Control of type 4 collagenase activity by components of the urokinase-plasmin system: A regulatory mechanism with cell-bound reactants. EMBO J., 16, 2319-2332.
12. Nagase, H. (1997) Activation mechanism of matrix metalloproteinases. Biol. Chem., 378, 151-160.
13. Reponen, P., Sahlberg, C., Munaut, C., Thesleff, I. & Tryggvason, K. (1994) High expression of 92-kD type 4 collagenase (gelatinase B) in the osteoclast lineage during mouse development. J. Cell. Biol., 124, 1091-1102.
14. Rodan, G.A. & Fleisch, H. (1996) Bisphosphonates: Mechanism of action. J. Clin. Invest., 97, 2692-2696.
15. Storm, T., Thamsborg, G., Steiniche, T., Genant, H.K. & Soerensen, O.H. (1990) Effect of intermittent cyclical etidronate treatment of postmenopausal osteoporosis. New. Engl. J. Med., 322, 1265-1271.
16. Takahashi, N., Akatsu, T., Udagawa, N., Sasaki, T., Yamaguchi, A., Moseley, J.M., Martin, T.J. & Suda, T. (1988) Osteoblastic cells are involved in osteoclast formation. Endocrinology, 123, 2600-2602.
17. Varghese, S., Yu, K. & Canalis, E. (1999) Leukemia inhibitory factor and oncostatin M stimulate collagenase-3 expression in osteoblasts. Am. J. Physiol., 276, E465-E471.